Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial

被引：0
|
作者：
Tabberer, Maggie [1 ]
Jones, Christine Elaine [2 ]
Kilbride, Sally [1 ]
Criner, Gerard J. [3 ]
Lange, Peter [4 ]
Han, Meilan K. [5 ]
Martinez, Fernando [6 ]
Lipson, David A. [7 ]
机构：
[1] GSK, Uxbridge, Middx, England
[2] GSK, Res Triangle Pk, NC USA
[3] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Univ Michigan, Pulm & Crit Care, Ann Arbor, MI 48109 USA
[6] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA
[7] GSK, King Of Prussia, PA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA1996
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1996
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
    Nicola C. Day
    Subramanya Kumar
    Gerard Criner
    Mark Dransfield
    David M. G. Halpin
    MeiLan K. Han
    C. Elaine Jones
    Morrys C. Kaisermann
    Sally Kilbride
    Peter Lange
    David A. Lomas
    Neil Martin
    Fernando J. Martinez
    Dave Singh
    Robert Wise
    David A. Lipson
    Respiratory Research, 21
  • [42] Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
    Day, Nicola C.
    Kumar, Subramanya
    Criner, Gerard
    Dransfield, Mark
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kaisermann, Morrys C.
    Kilbride, Sally
    Lange, Peter
    Lomas, David A.
    Martin, Neil
    Martinez, Fernando J.
    Singh, Dave
    Wise, Robert
    Lipson, David A.
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [43] LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
    Lomas, David
    Lipson, David
    Barnacle, Helen
    Birk, Ruby
    Brealey, Noushin
    Zhu, Chang-Qing
    Tabberer, Maggie
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [44] Chinese subgroup results from a study comparing single-inhaler triple therapy with dual therapy in COPD
    Liu, Cindy
    Luo, Linda
    Du, Xin
    Xiao, Lochy
    Goh, Aik Han
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [45] Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in England
    Noorduyn, Stephen G.
    Wood, Robert P.
    Rothnie, Kieran J.
    Rai, Kiran K.
    Seif, Monica
    Massey, Lucy
    Compton, Chris
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [46] Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation
    Ismaila, A.
    Wood, R.
    Czira, A.
    Banks, V
    Camidge, L.
    Massey, O.
    Sharma, R.
    Compton, C.
    Rothnie, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [47] Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses
    Lipson, David
    Barnacle, Helen
    Birk, Ruby
    Brealey, Noushin
    Zhu, Chang-Qing
    Dransfield, Mark
    Lomas, David
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [48] Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study - The TRIBUNE study
    Porpodis, Konstantinos
    Bartziokas, Konstantinos
    Chatziapostolou, Panagiotis
    Korkontzelou, Aliki
    Katerelos, Panos
    Efstathopoulos, Petros
    Bakakos, Petros
    RESPIRATORY MEDICINE, 2023, 212
  • [49] A SYSTEMATIC REVIEW OF SINGLE-INHALER TRIPLE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Langham, S.
    Lewis, J.
    Pooley, N.
    Embleton, N.
    Langham, J.
    VALUE IN HEALTH, 2019, 22 : S873 - S873
  • [50] ECONOMIC IMPACT OF DELAYING INITIATION WITH MULTIPLE INHALER MAINTENANCE TRIPLE THERAPY TREATMENT IN SPANISH COPD PATIENTS
    Sicras-Mainar, A.
    Huerta, A.
    Navarro-Artieda, R.
    Monso, E.
    Landis, S.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S407 - S407
12345